Rituximab and/or Lenalidomide in Treating Patients With Follicular Non-Hodgkin's Lymphoma That is Not Refractory to Rituximab
Completed · Phase 2
Conditions studied: Lymphoma
In brief
Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some block the ability of cancer cells to grow and spread. Others find cancer cells and help kill them or carry cancer-killing substances to them. Biological therapies, such as lenalidomide, may stimulate the immune system in different ways and stop cancer cells from growing. Lenalidomide may also stop the growth of non-Hodgkin's lymphoma by blocking blood flow to the cancer. Giving rituximab together with lenalidomide may kill more cancer cells. This randomized phase II trial is studying how well rituximab and/or lenalidomide work in treating patients with follicular non-Hodgkin's lymphoma that is not refractory to rituximab.
Key facts
- Study ID
- NCT00238238
- Run by
- Alliance for Clinical Trials in Oncology
- People needed
- 97
- Starts
- 2006-03-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2017-03-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kaiser Permanente Medical Office -Vandever Medical Office — San Diego, California, United States
- Walter Reed Army Medical Center — Washington D.C., District of Columbia, United States
- Michael and Dianne Bienes Comprehensive Cancer Center at Holy Cross Hospital — Fort Lauderdale, Florida, United States
- Ella Milbank Foshay Cancer Center at Jupiter Medical Center — Jupiter, Florida, United States
- CCOP - Mount Sinai Medical Center — Miami Beach, Florida, United States
- Illinois CancerCare - Bloomington — Bloomington, Illinois, United States
- Graham Hospital — Canton, Illinois, United States
- Illinois CancerCare - Canton — Canton, Illinois, United States
- Illinois CancerCare - Carthage — Carthage, Illinois, United States
- Memorial Hospital — Carthage, Illinois, United States
- University of Chicago Cancer Research Center — Chicago, Illinois, United States
- Eureka Community Hospital — Eureka, Illinois, United States
- Illinois CancerCare - Eureka — Eureka, Illinois, United States
- Galesburg Clinic, PC — Galesburg, Illinois, United States
- Galesburg Cottage Hospital — Galesburg, Illinois, United States
- Illinois CancerCare - Galesburg — Galesburg, Illinois, United States
- Illinois CancerCare - Havana — Havana, Illinois, United States
- Mason District Hospital — Havana, Illinois, United States
- Illinois CancerCare - Kewanee Clinic — Kewanee, Illinois, United States
- Illinois CancerCare - Macomb — Macomb, Illinois, United States
- McDonough District Hospital — Macomb, Illinois, United States
- Illinois CancerCare - Monmouth — Monmouth, Illinois, United States
- BroMenn Regional Medical Center — Normal, Illinois, United States
- Community Cancer Center — Normal, Illinois, United States
- Rebecca and John Moores UCSD Cancer Center — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.